Israeli Biotech Firm Trying To Print Organs For Transplants
Image by iStock
Israeli biotech firm CollPlant is trying to patent a technology that that could eventually lead to the three-dimensional printing of hearts, kidneys and other vital human tissues.
CollPlant, based in Ness Ziona, has filed a patent application in the United States for its “bio-ink” – made of a proprietary plant product that mimics the qualities of collagen, a protein responsible for the elasticity of human skin and other organs.
Combined with other hormones and existing human cells, the bio-ink could eventually be used to create organs for those in need – easing pressure on the transplant process, which for the most part relies on harvested organs from the deceased.
“We are promoting commercial collaborations with leading international companies in the field of 3D bio-printing of tissue and organ, with the aim of taking part in providing a solution to the significant need for life saving organs,” Yehiel Tal, CEO of CollPlant, told the Jerusalem Post.
Contact Daniel J. Solomon at [email protected] or on Twitter @DanielJSolomon
It’s our birthday and we’re still celebrating!
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news.
This week we celebrate 129 years of the Forward. We’re proud of our origins as a Yiddish print publication serving Jewish immigrants. And we’re just as proud of what we’ve become today: A trusted source of Jewish news and opinion, available digitally to anyone in the world without paywalls or subscriptions.
We’ve helped five generations of American Jews make sense of the news and the world around them — and we aren’t slowing down any time soon.
As a nonprofit newsroom, reader donations make it possible for us to do this work. Support independent, agenda-free Jewish journalism and our board will match your gift in honor of our birthday!
Support our mission to tell the Jewish story fully and fairly.
